| Tag | Content |
|---|
EnhancerAtlas ID | HS197-11309 |
Organism | Homo sapiens |
Tissue/cell | ZR75-30 |
Coordinate | chr2:31604840-31605860 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr2:31605551-31605569 | GGGAGGGAGGCAGGAAGC | + | 6.43 | | PBX1 | MA0070.1 | chr2:31604845-31604857 | TTTGATTGATGA | - | 6.74 | | RELA | MA0107.1 | chr2:31605464-31605474 | GGAAATTCCC | - | 6.02 | | SCRT1 | MA0743.1 | chr2:31605398-31605413 | AATCAACAGGTGTAT | + | 6.32 | | SCRT2 | MA0744.1 | chr2:31605398-31605411 | AATCAACAGGTGT | + | 6.11 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_36119 | chr2:31605117-31609731 | HMEC | | SE_65049 | chr2:31605499-31609237 | NHEK |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I031381 | chr2 | 31604321 | 31609680 |
|
Enhancer Sequence | GTGTGTTTGA TTGATGATTT CACCCAACCT TTTCCCGAAA GGATTGAGGT GATTTATCAC 60
AGAGGCCATA TAGACTTAGT AAAATAGAAG ATAAAGATCA AGGAAAGAGA GGAGGAAGAC 120
TTAAGGTTGA ACAATTTGCT CTATTTGGAT CTGAACTTCC TGGTAACTTG GCAAAAAAAA 180
TGTAAGAAGA ATCAGATACA GGGTTCTCGT TATTAGAAAA CAGGAAGAAA ATCAGTTGCA 240
CGATGAAAAT ACAATTCTTC CTGGAAATAG ATTTTAGCAG AACTAGGGAA CTCAGCAGAG 300
TTTTTGAGTT TATGTTTCCT TATCTACAGT TTATGTTTCC TTATCTATAA TCAGAAGTGA 360
CAGGTACTTG GGGTGGGGGC TGGGAGGAAT AGGAGTAGGC TGTTTTGTTT TAATTTAAAA 420
AAACAATTTA AAAATGGAAG AGATAGCTTT TCTTCCGACA CCATAAACTG TTGTGAAGAG 480
CTTCCATTGG CATAGGGTGT TCGAATGCCA CCATTTGCAA ACTGGGAATG TGGGGACTTG 540
TCTGAAGGCT GACTGAATAA TCAACAGGTG TATTCCTCCC TCTGTGGGAG GGCTCTGTCT 600
CTGGTTCTCC CTATAGCTCT GAAAGGAAAT TCCCCTCTCA ATTCTGACTT CTCCCTAGCA 660
TATCCATATC TCTTGTTCAC CTACTGTTTG GCTCAGCCAA GCTCAGGAAG GGGGAGGGAG 720
GCAGGAAGCC TCATCTCTGC AACCACAGAA TGAAGCCTAT GAGTCGTGGA GTGCATTTCC 780
CAGGGTGCCC CACAGACCAC CTTCATCAGA AGCACCTGAA GAGCTGGGCT ACATCCCAGA 840
CCCATGTATC AGAATCTCTG AGGGTGGGGC CCAGGAATCT GCACTTTAAC AAGCACTGCT 900
CCTCCCAGGC AACTCTAAGC GCTAAAGTTT GAGGCCCACT GCACTGACAC AGTGAGAGTC 960
TGGCTGCCCT GCTTTCAGAT GAAAGCTCCA TCCTACGGGC CTCGCTTGCT TCTGAGAGCG 1020
|
